Data Presented by Independent Academic Collaborators Demonstrate Ability of Novel Manocept™ Immunotherapy to Kill Activated Macrophages from KS Patients Dec 15, 2014
Macrophage Therapeutics to Present Data Supporting Potential for Breakthrough with Manocept™ in Immunotherapy Dec 12, 2014
Navidea Forms Macrophage Therapeutics Business Unit to Explore Therapeutic Applications of Manocept™ Dec 10, 2014
Navidea Receives $1.1Million PDUFA Filing Fee Refund for Award of Orphan Drug Status; Platinum Partners Reaffirms Commitment to Line of Credit Nov 11, 2014
Navidea Announces Scientific Presentations of Results from Lymphoseek® Studies at the European Association of Nuclear Medicine and European Society of Surgical Oncology Meetings Oct 30, 2014